In addition, E-Cadherin plays an important role in controlling cell migration via PI3K-associated mechanism [33–35], and it was newly reported that loss of of E-Cadherin was associated with tumor metastasis in patients with NSCLC [36]. The gene discussed is CDH1; the disease is neoplasm.